PD 184,352

MEK (MAPKK) inhibitor. Potent and selective MAPK (ERK kinase 1; MEK1) activation inhibitor (IC50 = 300 nM in vitro, IC50 = 2 nM in vivo). Suppresses activation of MAPK but does not block its activity. Antiproliferative. Causes cell-cycle arrest in G1 phase. Tumor suppressor. Apoptosis inducer.

Price Not Available 5 mg PD 184,352 Supplier Page
Catalog Number AG-CR1-0029-M005
Alternative Name(s) 2-(2-Chloro-4-iodo-phenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide; CI-1040
Research Area Apoptosis, Biochemicals, Cancer, Cell Death
Molecular Formula C17H14ClF2IN2O2
CAS# 212631-79-3
Purity >95%
Inchi InChI=1S/C17H14ClF2IN2O2/c18-12-7-10(21)3-6-14(12)22-16-11(4-5-13(19)15(16)20)17(24)23-25-8-9-1-2-9/h3-7,9,22H,1-2,8H2,(H,23,24)
Inchi Key GFMMXOIFOQCCGU-UHFFFAOYSA-N
SMILES FC1=C(F)C(NC2=CC=C(I)C=C2Cl)=C(C=C1)C(=O)NOCC1CC1
Size 5 mg
Supplier Page http://www.adipogen.com/ag-cr1-0029/pd-184-352.html